It seems Valley Fever is spreading. Some of the increase may be explained by improved diagnosis, but other factors are also at work; including increased migration and visitation to the Southwest where coccidioidomycosis is endemic. The director of the Valley Fever Center for Excellence and BIO5 member Dr. John Galgiani, weighs in on the challenges and progress regarding the development of a vaccine for the disease.
Related
